In Part 5 of the SEC deposition tapes, former Theranos CEO Elizabeth Holmes is questioned in detail regarding Theranos' retail partnerships, internal financial tracking, and revenue projections provided to investors and the board. Holmes addresses the status of the Safeway and CVS discussions, the reality behind blood testing operations and reference labs, and how financial models were constructed and handled alongside former COO Sunny Balwani. The testimony dives into key discrepancies between historical financial statements, IRS filings, and the ambitious revenue forecasts shared with potential investors. Listen To Hidden Killers Podcast ANYWHERE! Listen Here: https://linktr.ee/hiddenkillers Join Our SubStack For AD-FREE ADVANCE EPISODES & EXTRAS!: https://hiddenkillers.substack.com/ Instagram https://www.instagram.com/hiddenkillerspod/ Facebook https://www.facebook.com/hiddenkillerspod/ Tik-Tok https://www.tiktok.com/@hiddenkillerspod X Twitter https://x.com/tonybpod This publication contains commentary and opinion based on publicly available information. All individuals are presumed innocent until proven guilty in a court of law. Nothing published here should be taken as a statement of fact, health or legal advice.